J84.178
Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere
Clinical Classification Guidelines
Inclusion Terms
- Interstitial pneumonia (nonspecific) (usual) due to collagen vascular disease
- Interstitial pneumonia (nonspecific) (usual) in diseases classified elsewhere
- Organizing pneumonia due to collagen vascular disease
- Organizing pneumonia in diseases classified elsewhere
Code First
- underlying disease, such as:
- progressive systemic sclerosis (M34.0)
- rheumatoid arthritis (M05.00-M06.9)
- systemic lupus erythematosis (M32.0-M32.9)
Medical Intelligence & Overview
ICD-10 code J84.178 refers to a group of interstitial lung diseases characterized by fibrosis, a condition where lung tissue becomes thickened and scarred. These diseases fall under the category of interstitial pulmonary diseases, which affect the tissue and space around the air sacs in the lungs. The term 'with fibrosis in diseases classified elsewhere' indicates that these conditions are part of broader disease categories, often associated with autoimmune or connective tissue disorders. Recognizing the signs, potential causes, and diagnostic methods for these conditions can help in understanding their complexity and impact on lung health.
Causes & Symptoms
Clinical Causes: Collagen vascular diseases, such as rheumatoid arthritis, systemic sclerosis, and lupus, which can lead to inflammation and scarring in the lungs. Nonspecific interstitial pneumonia that develops in association with autoimmune conditions. Organizing pneumonia linked to underlying connective tissue disorders. Environmental exposures, including inhalation of inorganic dust or toxic fumes, that may trigger or exacerbate fibrosis. Idiopathic cases where no specific cause is identified, but fibrosis develops as a primary process.
Key Symptoms: Shortness of breath, especially during physical activity Persistent dry cough Fatigue and general feeling of tiredness Chest discomfort or pain Clubbing of fingers (enlargement of the fingertips) Unintentional weight loss in advanced stages
Diagnostic & Treatment
Diagnosis Path: Diagnosing these interstitial lung diseases involves a combination of clinical evaluation and specialized testing. Methods include:
Treatment Protocols: While there is no cure for interstitial pulmonary fibrosis, especially when associated with underlying conditions, management focuses on slowing disease progression and alleviating symptoms. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is J84.178 a billable ICD-10 code?
Yes, J84.178 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J84.178?
Clinical documentation must specify the nature of Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere and any associated comorbidities for accurate reporting.
Cite this Clinical Reference